We are live on ! Find out more
CRDL

Cardiol Therapeutics
CRDL

35 hedge funds and large institutions have $5.78M invested in Cardiol Therapeutics in 2023 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more call options, than puts

Call options by funds: $5K | Put options by funds: $1K

167% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 3

33% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 6

6% more funds holding

Funds holding: 33 → 35 (+2)

0.58% less ownership

Funds ownership: 10.45% → 9.86% (-0.58%)

3% less capital invested

Capital invested by funds: $5.97M → $5.78M (-$190K)

Holders
35
Holders Change
+2
Holders Change %
+6.06%
% of All Funds
0.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
8
Reduced
3
Closed
6
Calls
$5K
Puts
$1K
Net Calls
+$4K
Net Calls Change
+$6K

Top Buyers

Rank Fund Capital Flow
1
TC
Tejara Capital
United Kingdom
+$142K
2
CS
Credit Suisse
Switzerland
+$47.8K
3
LNWTC
Laird Norton Wetherby Trust Company
Washington
+$36.9K
4
FIA
FNY Investment Advisers
New York
+$31.8K
5
MA
MONECO Advisors
Connecticut
+$13.4K

Top Sellers

Rank Fund Capital Flow
1
AI
AXS Investments
New York
-$502K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$32.6K
3
N
Natixis
France
-$22.4K
4
Citadel Advisors
Citadel Advisors
Florida
-$15.8K
5
AI
AdvisorShares Investments
Maryland
-$13.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
FDCDDQ
26
Federation des caisses Desjardins du Quebec
Quebec, Canada
$1.59K – – –
Group One Trading
27
Group One Trading
Illinois
$1.53K +$1.59K +1,666 +166,600%
BEI
28
Benjamin Edwards Inc
Missouri
$1K – – –
CSB
29
City State Bank
Iowa
$1K – – –
RA
30
Rise Advisors
New York
$895 – – –
SC
31
SouthState Corp
Florida
$895 – – –
Wells Fargo
32
Wells Fargo
California
$137 +$143 +150 New
Morgan Stanley
33
Morgan Stanley
New York
$90 +$96 +100 New
Toronto Dominion Bank
34
Toronto Dominion Bank
Ontario, Canada
$23 +$25 +26 New
Susquehanna International Group
35
Susquehanna International Group
Pennsylvania
– -$32.6K -36,613 Closed
N
36
Natixis
France
– -$22.4K -25,000 Closed
Citadel Advisors
37
Citadel Advisors
Florida
– -$15.8K -17,743 Closed
TSS
38
Two Sigma Securities
New York
– -$11.9K -13,359 Closed
NC
39
NewSquare Capital
Pennsylvania
– -$623 -700 Closed
OLVIG
40
Oliver Lagore Vanvalin Investment Group
Michigan
– -$445 -500 Closed
Simplex Trading
41
Simplex Trading
Illinois
– +$205 +215 +26%
1
2

CRDL Hedge Fund Activity: Q3 2023 in Review

35 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Cardiol Therapeutics (CRDL) for Q3 2023, worth a combined $5.78M — down 3.2% from $5.97M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new CRDL positions and 6 closed out — a net gain of 2 holders — while 8 added to existing stakes and 3 trimmed.

The largest buyer was Tejara Capital, adding an estimated $142K. The largest seller was AXS Investments, cutting an estimated $502K.

  • 35 institutional investors held Cardiol Therapeutics (CRDL) as of Q3 2023, up from 33 in Q2 2023.
  • Funds reported $5.78M of Cardiol Therapeutics stock for Q3 2023, down 3.2% quarter-over-quarter.
  • 8 funds opened new Cardiol Therapeutics positions in Q3 2023 and 6 closed out, a net change of +2 holders.
  • The largest Cardiol Therapeutics buyer in Q3 2023 was Tejara Capital, an estimated $142K added.
  • The largest Cardiol Therapeutics seller in Q3 2023 was AXS Investments, an estimated $502K sold.

Based on aggregated 13F filings for Q3 2023.